Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Cyclica Academic Partnership Program (CAPP): Research Awards Supporting Small Molecule Drug Discovery Through AI Platforms

Cyclica

As part of the Cyclica Academic Partnership Program (CAPP) , Cyclica offers two research awards to support small molecule drug screening and discovery efforts at Duke University. Successful applicants will receive in-kind access to Cyclica's AI-augmented medicinal chemistry platforms, Ligand Express or Ligand Design. Cyclica's technology is disease agnostic, and we encourage all faculties working on small molecule drug discovery to take advantage of these awards:

The Ligand Express Award:

Apply if your lab works on small molecule drug screening
Receive in-kind access to the Ligand Express online platform for 3 months, with the possibility of extension
Screen molecules against the human proteome to elucidate mechanisms of action, ADMET predictions, and repurposing opportunities
Learn more about the Ligand Express Award and apply here

The Ligand Design Award :

Apply if your lab seeks novel small molecules drugs for your protein(s) of interest
Receive in-kind access to the Ligand Design technology for 6-12 months
Collaborate with Cyclica’s applied scientists to design, optimize, and synthesize novel molecules for desired therapeutic targets, anti-targets, and ADMET properties
Tap into Cyclica's network of venture capitals and pharmaceutical companies to advance the commercialization of novel small molecule IP
Learn more about the Ligand Design Award and apply here

Cyclica is committed to award at least two labs at Duke University. For any inquiries regarding the award process, please contact Cyclica's Strategic Partnerships Manager, Maurice Shen .

Specialties

Medical

Medical - Translational

Medical - Basic Science

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: Cyclica

Address: NA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity